Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    HT Staff

    News

    Findings may help advance treatment of malaria

    Author:
    HT Staff
    Publish date: November 13, 2015

    Researchers have found that a screening model can classify antimalarial drugs and reveal drug targets for Plasmodium falciparum, according to a...

    • Read More

    News

    Team evaluates long-term tolerability of ticagrelor

    Author:
    HT Staff
    Publish date: November 13, 2015

    Photo courtesy of AstraZeneca ORLANDO, FL—A subanalysis of the PEGASUS-TIMI 54 trial has provided a clearer picture of the risks and benefits...

    • Read More

    News

    Pharma companies fail to disclose trial information

    Author:
    HT Staff
    Publish date: November 13, 2015

    Photo by Esther Dyson New research indicates that pharmaceutical companies are still failing to disclose trial information publicly, despite...

    • Read More

    News

    ESRD treatments linked to different cancers

    Author:
    HT Staff
    Publish date: November 13, 2015

    Photo by Anna Frodesiak Patients with end-stage renal disease (ESRD) may have different cancer risks according to the treatment they are...

    • Read More

    News

    Analysis suggests dabigatran is safer than warfarin

    Author:
    HT Staff
    Publish date: November 12, 2015

    ORLANDO, FL—Interim results from a long-term, “real world” study suggest dabigatran etexilate mesylate (Pradaxa) may be safer than warfarin in...

    • Read More

    News

    Antidote reverses effects of apixaban, rivaroxaban in healthy subjects

    Author:
    HT Staff
    Publish date: November 12, 2015

    An investigational antidote to factor Xa inhibitors has proven succesful in reversing the effects of apixaban and rivaroxaban in a pair of phase 3...

    • Read More

    News

    Drug ‘life-changing’ for CLL patients in phase 1 trial

    Author:
    HT Staff
    Publish date: November 12, 2015

    Photo courtesy of NIH A novel Bruton’s tyrosine kinase inhibitor has proven life-changing for patients with chronic lymphocytic leukemia (CLL) who...

    • Read More

    News

    Inhibitor exhibits ‘modest’ activity in lymphoma

    Author:
    HT Staff
    Publish date: November 12, 2015

    A small-molecule inhibitor has shown modest anticancer activity in a phase 1 trial of patients with relapsed/refractory lymphoma or multiple...

    • Read More

    News

    Predicting risk of VTE in patients with leg casts

    Author:
    HT Staff
    Publish date: November 11, 2015

    Photo by Nikki McLeod Researchers say they have developed prediction models and a scoring system that can help identify a high risk of venous...

    • Read More

    News

    Relapses ‘critical’ for sustained malaria transmission

    Author:
    HT Staff
    Publish date: November 11, 2015

    Plasmodium vivax Image by Mae Melvin New research indicates that most childhood malaria infections in Papua New Guinea (PNG) are the result of...

    • Read More

    News

    CCSs have increased risk of autoimmune diseases

    Author:
    HT Staff
    Publish date: November 11, 2015

    Photo by Bill Branson Childhood cancer survivors (CCSs) have an increased risk of developing autoimmune diseases, according to research published...

    • Read More

    News

    Study raises questions about iron dosing

    Author:
    HT Staff
    Publish date: November 10, 2015

    A new study suggests it may be difficult for the body to absorb iron in the necessary or desired quantities when iron supplements are administered...

    • Read More

    News

    Drug protects fertility in chemo-treated mice

    Author:
    HT Staff
    Publish date: November 10, 2015

    Photo courtesy of UW Health The heart medication dexrazoxane can protect fertility and improve survival in female mice receiving the...

    • Read More

    News

    Models predict impact of malaria vaccine candidate

    Author:
    HT Staff
    Publish date: November 10, 2015

    Photo by Caitlin Kleiboer The malaria vaccine candidate RTS,S/AS01 (Mosquirix) could have a significant impact on public health in a range of...

    • Read More

    News

    Team describes new way to edit HSPCs

    Author:
    HT Staff
    Publish date: November 10, 2015

    Image by Tom Ellenberger Researchers say they have discovered a more efficient way to edit the genomes of hematopoietic stem and progenitor cells...

    • Read More

    Pages

    • « first
    • …
    • 147
    • 148
    • 149
    • 150
    • 151
    • 152
    • 153
    • 154
    • 155
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery